REFERENCES
- Jablensky A. Epidemiology of schizophrenia: the global burden of disease and disability. Eur Arch Psychiatry Clin Neurosci 2000; 250: 274–85, [PUBMED], [INFOTRIEVE], [CSA]
- Harris E C, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry 1998; 173: 11–53, [PUBMED], [INFOTRIEVE]
- Bengtsson-Tops A, Hansson L. Subjective quality of life in schizophrenic patients living in the community. Relationship to clinical and social characteristics. Eur Psychiatry 1999; 14: 256–63
- Thara R. Twenty-year course of schizophrenia: the Madras Longitudinal Study. Can J Psychiatry 2004; 49: 564–9, [PUBMED], [INFOTRIEVE], [CSA]
- Turner T H. Long-term outcome of treating schizophrenia. BMJ 2004; 329: 1058–9, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Knapp M. Costs of schizophrenia. Br J Psychiatry 1997; 171: 509–18, [PUBMED], [INFOTRIEVE]
- Thompson K. Stigma and public health policy for schizophrenia. Psychiatr Clin North Am 2003; 26: 273–94, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rupp A, Keith S J. The costs of schizophrenia. Assessing the burden. Psychiatr Clin North Am 1993; 16: 413–23, [CSA]
- Rice D P. The economic impact of schizophrenia. J Clin Psychiatry 1999; 60(suppl 1)4–6, discussion 28–30[PUBMED], [INFOTRIEVE]
- Geddes J, Freemantle N, Harrison P, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ 2000; 321: 1371–6, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Falloon I R, Boyd J L, McGill C W, et al. Family management in the prevention of morbidity of schizophrenia. Clinical outcome of a two-year longitudinal study. Arch Gen Psychiatr 1985; 42: 887–96, [PUBMED], [INFOTRIEVE]
- Mosher L R. Soteria and other alternatives to acute psychiatric hospitalization: a personal and professional review. J Nerv Ment Dis 1999; 187: 142–9, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cardno A G, Gottesman I I. Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. Am J Med Genet 2000; 97: 12–7, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Prasad S, Semwal P, Deshpande S, Bhatia T, Nimgaonker V L, Thelma B K. Molecular genetics of schizophrenia: past, present and future. J Biosci 2002; 27: 35–52, [PUBMED], [INFOTRIEVE], [CSA]
- Tsuang M T, Faraone S V. The case for heterogeneity in the etiology of schizophrenia. Schizophr Res 1995; 17: 161–75, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Owen M J, Williams N M, O'Donovan M C. The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatr 2004; 9: 14–27, [CSA], [CROSSREF]
- Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 2004; 40: 881–4, [CSA], [CROSSREF]
- Aghajanian G K, Marek G J. Serotonin model of schizophrenia: emerging role of glutamate mechanisms. Brain Res Brain Res Rev 2000; 31: 302–12, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Laruelle M, Kegeles L S, Abi-Dargham A. Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann N Y Acad Sci 2003; 1003: 138–58, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- O'Donnell P, Grace A A. Dysfunctions in multiple interrelated systems as the neurobiological bases of schizophrenic symptom clusters. Schizophr Bull 1998; 24: 267–83, [PUBMED], [INFOTRIEVE], [CSA]
- Johnstone E C, Crow T J, Frith C D, Husband J, Kreel L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet 1976; 2: 924–6, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Weinberger D R, DeLisi L E, Perman G P, Targum S, Wyatt R J. Computed tomography in schizophreniform disorder and other acute psychiatric disorders. Arch Gen Psychiatry 1982; 39: 778–83, [PUBMED], [INFOTRIEVE]
- Weinberger D R. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 1999; 45: 395–402, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cotter D, Takei N, Farrell M, et al. Does prenatal exposure to influenza in mice induce pyramidal cell disarray in the dorsal hippocampus?. Schizophr Res 1995; 16: 233–41, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Turetsky B I, Moberg P J, Yousem D M, Doty R L, Arnold S E, Gur R E. Reduced olfactory bulb volume in patients with schizophrenia. Am J Psychiatry 2000; 157: 828–30, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Marenco S, Weinberger D R. The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev Psychopathol 2000; 12: 501–27, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Marcus J, Hans S L, Nagler S, Aurbach J G, Mirsky A F, Aubrey A. Review of the NIMH Israeli Kibbutz-City Study and the Jerusalem Infant Development Study. Schizophr Bull 1987; 13: 425–38, [PUBMED], [INFOTRIEVE]
- Olin S C, Mednick S A. Risk factors of psychosis: identifying vulnerable populations premorbidly. Schizophr Bull 1996; 22: 223–40, [PUBMED], [INFOTRIEVE], [CSA]
- Ott S L, Roberts S, Rock D, Allen J, Erlenmeyer-Kimling L. Positive and negative thought disorder and psychopathology in childhood among subjects with adulthood schizophrenia. Schizophr Res 2002; 58: 231–9, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Davidson M, Weiser M. Early diagnosis of schizophrenia—the first step towards secondary prevention. Acta Psychiatr Scand Suppl 2000; 400: 7–10, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hulshoff Pol H E, Hoek H W, Susser E, et al. Prenatal exposure to famine and brain morphology in schizophrenia. Am J Psychiatry 2000; 157: 1170–2, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Brown A, Begg M, Gravenstein S, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004; 61: 774–80, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Jakob H, Beckmann H. Circumscribed malformation and nerve cell alterations in the entorhinal cortex of schizophrenics. Pathogenetic and clinical aspects. J Neural Transm Gen Sect 1994; 98: 83–106, [CSA], [CROSSREF]
- Conrad A J, Scheibel A B. Schizophrenia and the hippocampus: the embryological hypothesis extended. Schizophr Bull 1987; 13: 577–87, [PUBMED], [INFOTRIEVE]
- Akbarian S, Bunny W E, Jr, Potkin S G, et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development. Arch Gen Psychiatry 1993; 50: 169–77, [PUBMED], [INFOTRIEVE]
- Dalman C, Allebeck P, Cullberg J, Grunewald C, Koster M. Obstetric complications and the risk of schizophrenia: a longitudinal study of a national birth cohort. Arch Gen Psychiatry 1999; 56: 234–40, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brown A S, Susser E S, Butler P D, Richardson Andrews R, Kaufmann C A, Gorman J M. Neurobiological plausibility of prenatal nutritional deprivation as a risk factor for schizophrenia. J Nerv Ment Dis 1996; 184: 71–85, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Susser E, Neugebauer R, Hoek H W, et al. Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatry 1996; 53: 25–31, [PUBMED], [INFOTRIEVE], [CSA]
- Harrison G, Fouskakis D, Rasmussen F, Tynelius P, Sipos A, Gunnell D. Association between psychotic disorder and urban place of birth is not mediated by obstetric complications or childhood socio-economic position: a cohort study. Psychol Med 2003; 33: 723–31, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Tochigi M, Okazaki Y, Kato N, Sasaki T. What causes seasonality of birth in schizophrenia?. Neurosci Res 2004; 48: 1–11, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Abou-Saleh M, Coppen A. The biology of folate in depression: implications for nutritional hypothesis of the psychosis. J Psychiatr Res 1986; 20: 91–101, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lewis S W, Murray R M. Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. J Psychiatr Res 1987; 21: 413–21, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Torrey E F, Miller J, Rawlings R, Yolken R H. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res 1997; 28: 1–38, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- van Os J, Selten J P. Prenatal exposure to maternal stress and subsequent schizophrenia. The May 1940 invasion of The Netherlands. Br J Psychiatry 1998; 172: 324–6, [PUBMED], [INFOTRIEVE]
- Marcelis M, Takei N, van Os J. Urbanization and risk for schizophrenia: does the effect operate before or around the time of illness onset?. Psychol Med 1999; 29: 1197–203, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Johnson W G. DNA polymorphism-diet-cofactor-development hypothesis and the gene-teratogen model for schizophrenia and other developmental disorders. Am J Med Genet 1999; 88: 311–23, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Opler M G, Brown A S, Graziano J, et al. Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia. Environ Health Perspect 2004; 112: 548–52, [PUBMED], [INFOTRIEVE], [CSA]
- Sanborn M D, Abelsohn A, Campbell M, Weir E. Identifying and managing adverse environmental health effects: 3. Lead exposure. CMAJ 2002; 166: 1287–92, [PUBMED], [INFOTRIEVE], [CSA]
- Avila M T, Sherr J, Valentine L E, Blaxton T A, Thaker G K. Neurodevelopmental interactions conferring risk for schizophrenia: a study of dermatoglyphic markers in patients and relatives. Schizophr Bull 2003; 29: 595–605, [PUBMED], [INFOTRIEVE], [CSA]
- Lynberg M C, Khoury M J, Lu X, Cocian T. Maternal flu, fever, and the risk of neural tube defects: a population-based case-control study. Am J Epidemiol 1994; 140: 244–55, [PUBMED], [INFOTRIEVE], [CSA]
- Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991; 338: 131–7
- Craciunescu C N, Brown E C, Mar M H, Albright C D, Nadeau M R, Zeisel S H. Folic acid deficiency during late gestation decreases progenitor cell proliferation and increases apoptosis in fetal mouse brain. J Nutr 2004; 134: 162–6, [PUBMED], [INFOTRIEVE]
- Rosenquist T H, Finnell R H. Genes, folate and homocysteine in embryonic development. Proc Nutr Soc 2001; 60: 53–6, [PUBMED], [INFOTRIEVE]
- Shaw G M, Lammer E J, Wasserman C R, O'Malley C D, Tolarova M M. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptionally. Lancet 1995; 346: 393–6, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Muntjewerff J W, van der Put N, Eskes T, et al. Homocysteine metabolism and B-vitamins in schizophrenic patients: low plasma folate as a possible independent risk factor for schizophrenia. Psychiatry Res 2003; 121: 1–9, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Goff D C, Coyle J T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am J Psychiatry 2001; 158: 1367–77, [PUBMED], [CROSSREF]
- Fleming A, Copp A J. Embryonic folate metabolism and mouse neural tube defects. Science 1998; 280: 2107–9, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kumar K S, Govindaiah V, Naushad S E, Devi R R, Jyothy A. Plasma homocysteine levels correlated to interactions between folate status and methylene tetrahydrofolate reductase gene mutation in women with unexplained recurrent pregnancy loss. J Obstet Gynaecol 2003; 23: 55–8, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lucock M, Daskalakis I, Hinkins M, Yates Z. An examination of polymorphic genes and folate metabolism in mothers affected by a spina bifida pregnancy. Mol Genet Metab 2001; 73: 322–32, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wenstrom K D, Johanning G L, Johnston K E, DuBard M. Association of the C677T methylenetetrahydrofolate reductase mutation and elevated homocysteine levels with congenital cardiac malformations. Am J Obstet Gynecol 2001; 184: 806–12, discussion 812–7[PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Storti S, Vittorini S, Lascone M R, et al. Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects. Clin Chem Lab Med 2003; 41: 276–80, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- van Rooij I A, Vermeij-Keers C, Kluijtmans L A, et al. Does the interaction between maternal folate intake and the methylenetetrahydrofolate reductase polymorphisms affect the risk of cleft lip with or without cleft palate?. Am J Epidemiol 2003; 157: 583–91, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Molloy A M, Mills J L, McPartlin J, Kirke P N, Scott J M, Daly S. Maternal and fetal plasma homocysteine concentrations at birth: the influence of folate, vitamin B12, and the 5,10-methylenetetrahydrofolate reductase 677C → T variant. Am J Obstet Gynecol 2002; 186: 499–503, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Doolin M T, Barbaux S, McDonnell M, Hoess K, Whitehead A S, Mitchell L E. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 2002; 71: 1222–6, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- James S J. Maternal metabolic phenotype and risk of Down syndrome: beyond genetics. Am J Med Genet A 2004; 127: 1–4, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kalter H. Teratology in the 20th century: environmental causes of congenital malformations in humans and how they were established. Neurotoxicol Teratol 2003; 25: 131–282, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rosenquist T H, Ratashak S A, Selhub J. Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci U S A 1996; 93: 15227–32, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Steegers-Theunissen R P, Boers G H, Trijbels F J, et al. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects?. Metabolism 1994; 43: 1475–80, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wong W Y, Eskes T K, Kuijpers-Jagtman A M, et al. Nonsyndromic orofacial clefts: association with maternal hyperhomocysteinemia. Teratology 1999; 60: 253–7, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Levine R J, England L J, Sibai B M. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol 2002; 186: 1107, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Green N S. Folic acid supplementation and prevention of birth defects. J Nutr 2002; 132(8 suppl)2356S–2360S, [PUBMED], [INFOTRIEVE]
- Forrester S, Kovach M J, Smith R E, Rimer L, Wesson M, Kimonis V E. Kousseff syndrome caused by deletion of chromosome 22q11–13. Am J Med Genet 2002; 112: 338–42, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Seller M J, Mohammed S, Russell J, Ogilvie C. Microdeletion 22q11.2, Kousseff syndrome and spina bifida. Clin Dysmorphol 2002; 11: 113–5, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Karayiorgou M, Gogos J A. The molecular genetics of the 22q11-associated schizophrenia. Brain Res Mol Brain Res 2004; 132: 95–104, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Smythies J R, Gottfries C G, Regland B. Disturbances of one-carbon metabolism in neuropsychiatric disorders: a review. Biol Psychiatry 1997; 41: 230–3, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Singh S M, Murphy B, O'Reilly R L. Involvement of gene-diet/drug interaction in DNA methylation and its contribution to complex diseases: from cancer to schizophrenia. Clin Genet 2003; 64: 451–60, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Mattson M P. Methylation and acetylation in nervous system development and neurodegenerative disorders. Ageing Res Rev 2003; 2: 329–42, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Abdolmaleky H M, Smith C L, Faraone S V, et al. Methylomics in psychiatry: modulation of gene-environment interactions may be through DNA methylation. Am J Med Genet B Neuropsychiatr Genet 2004; 127: 51–9, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Brauer P R, Rosenquist T H. Effect of elevated homocysteine on cardiac neural crest migration in vitro. Dev Dyn 2002; 224: 222–30, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lipton S A, Kim W K, Choi Y B, et al. Neurotoxicity associated with dual actions of homocysteine at the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A 1997; 94: 5923–8, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rosenquist T H, Schneider A M, Monogham D T. N-methyl-D-aspartate receptor agonists modulate homocysteine-induced developmental abnormalities. FASEB J 1999; 13: 1523–31, [PUBMED], [INFOTRIEVE], [CSA]
- Lee H, Choi B H. Density and distribution of excitatory amino acid receptors in the developing human fetal brain: a quantitative autoradiographic study. Exp Neurol 1992; 118: 284–90, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hirasawa T, Wada H, Kohsaka S, Uchino S. Inhibition of NMDA receptors induces delayed neuronal maturation and sustained proliferation of progenitor cells during neocortical development. J Neurosci Res 2003; 74: 676–87, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Okabe S, Vicario-Abejon C, Segal M, McKay R D. Survival and synaptogenesis of hippocampal neurons without NMDA receptor function in culture. Eur J Neurosci 1998; 10: 2192–8, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Oshima S, Fukaya M, Masabumi N, Shirakawa T, Oguchi H, Watanabe M. Early onset of NMDA receptor GluR epsilon 1 (NR2A) expression and its abundant postsynaptic localization in developing motoneurons of the mouse hypoglossal nucleus. Neurosci Res 2002; 43: 239–50, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ikonomidou C, Bosch F, Miksa M, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999; 283: 70–4, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Waddington J L, Lane A, Scully P, et al. Early cerebro-craniofacial dysmorphogenesis in schizophrenia: a lifetime trajectory model from neurodevelopmental basis to ‘neuroprogressive’ process. J Psychiatr Res 1999; 33: 477–89, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Soo K, O'Rourke M P, Khoo P L, et al. Twist function is required for the morphogenesis of the cephalic neural tube and the differentiation of the cranial neural crest cells in the mouse embryo. Dev Biol 2002; 247: 251–70, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Rosenberg N, Murata M, Ikeda Y, et al. The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am J Hum Genet 2002; 70: 758–62, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Arinami T, Yamada N, Yamakawa-Kobayashi K, Hamaguchi H, Toru M. Methylenetetrahydrofolate reductase variant and schizophrenia/depression. Am J Med Genet 1997; 74: 526–8, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Deng H, Liu X, Cai G, et al. [A linkage disequilibrium study of methylenetetrahydrofolate reductase C677T and schizophrenia]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002; 19: 198–200, [PUBMED], [INFOTRIEVE], [CSA]
- Sazci A, Ergul E, Guzelhan Y, Kaya G, Kara I. Methylenetetrahydrofolate reductase gene polymorphisms in patients with schizophrenia. Brain Res Mol Brain Res 2003; 117: 104–7, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Virgos C, Martorell L, Simo J M, et al. Plasma homocysteine and the methylenetetrahydrofolate reductase C677T gene variant: lack of association with schizophrenia. Neuroreport 1999; 10: 2035–8, [PUBMED], [INFOTRIEVE], [CSA]
- Levine J, Stahl Z, Sela B A, Gavendo S, Ruderman V, Belmaker R H. Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry 2002; 159: 1790–2, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mills J L, McPartlin J M, Kirke P N, et al. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 1995; 345: 149–51, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Lucock M, Daskalakis I, Briggs D, Yates Z, Levene M. Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677C → T methylenetetrahydrofolate reductase and 2756A → G methionine synthase genotypes. Mol Genet Metab 2000; 70: 27–44, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Hobbs C A, Cleves M A, Lauer R M, Burns T L, James S J. Preferential transmission of the MTHFR 677 T allele to infants with Down syndrome: implications for a survival advantage. Am J Med Genet 2002; 113: 9–14, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Kluijtmans L A, Young I S, Boreham C A, et al. Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults. Blood 2003; 101: 2483–8, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Afman L A, Lievers K J, van der Put N M, Trijbels F J, Blom H J. Single nucleotide polymorphisms in the transcobalamin gene: relationship with transcobalamin concentrations and risk for neural tube defects. Eur J Hum Genet 2002; 10: 433–8, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lievers K J, Afman L A, Kluijtmans L A, et al. Polymorphisms in the transcobalamin gene: association with plasma homocysteine in healthy individuals and vascular disease patients. Clin Chem 2002; 48: 1383–9, [PUBMED], [INFOTRIEVE], [CSA]
- Gueant-Rodriguez R M, Rendeli C, Namour B, et al. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett 2003; 344: 189–92, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Winkelmayer W C, Eberle C, Sunder-Plassmann G, Fodinger M. Effects of the glutamate carboxypeptidase II (GCP2 1561C > T) and reduced folate carrier (RFC1 80G > A) allelic variants on folate and total homocysteine levels in kidney transplant patients. Kidney Int 2003; 63: 2280–5, [PUBMED], [INFOTRIEVE]
- Devlin A M, Ling E H, Peerson J M, et al. Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. Hum Mol Genet 2000; 9: 2837–44, [PUBMED], [INFOTRIEVE], [CSA]
- Vieira A R, Trembath D, Vandyke D C, et al. Studies with His475Tyr glutamate carboxipeptidase II polymorphism and neural tube defects. Am J Med Genet 2002; 111: 218–9, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Ghose S, Weickert C S, Colvin S M, et al. Glutamate carboxypeptidase II gene expression in the human frontal and temporal lobe in schizophrenia. Neuropsychopharmacology 2004; 29: 117–25, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Flores C, Coyle J T. Regulation of glutamate carboxypeptidase II function in corticolimbic regions of rat brain by phencyclidine, haloperidol, and clozapine. Neuropsychopharmacology 2003; 28: 1227–34, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Lievers K J, Kluijtmans L A, Boers G H, et al. Influence of a glutamate carboxypeptidase II (GCPII) polymorphism (1561C → T) on plasma homocysteine, folate and vitamin B(12) levels and its relationship to cardiovascular disease risk. Atherosclerosis 2002; 164: 269–73, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Mudd S, Levy H, Kraus J P. Disorders of transulfuration. The metabolic and molecular basis of inherited disease 8th ed., C R Scriver, A L Beaudet, W S Sly, et al. McGraw-Hill, New York 2000; 2007–56
- Ryan M M, Sidhu R K, Alexander J, Megerian J T. Homocystinuria presenting as psychosis in an adolescent. J Child Neurol 2002; 17: 859–60, [PUBMED], [INFOTRIEVE], [CSA]
- Afman L A, Lievers K J, Kluijtmans L A, Trijbels F J, Blom H J. Gene-gene interaction between the cystathionine beta-synthase 31 base pair variable number of tandem repeats and the methylenetetrahydrofolate reductase 677C > T polymorphism on homocysteine levels and risk for neural tube defects. Mol Genet Metab 2003; 78: 211–5, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Speer M C, Nye J, McLone D, et al. Possible interaction of genotypes at cystathionine beta-synthase and methylenetetrahydrofolate reductase (MTHFR) in neural tube defects. NTD Collaborative Group. Clin Genet 1999; 56: 142–4, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Honein M A, Paulozzi L J, Mathews T J, Erickson J D, Wong L Y. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001; 285: 2981–6, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Frenkel E P, Yardley D A. Clinical and laboratory features and sequelae of deficiency of folic acid (folate) and vitamin B12 (cobalamin) in pregnancy and gynecology. Hematol Oncol Clin North Am 2000; 14: 1079–100, viii, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Ray J G, Meier C, Vermeulen M J, Cole D E, Wyatt P R. Prevalence of trisomy 21 following folic acid food fortification. Am J Med Genet A 2003; 120: 309–13, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Oleary M, Donnell R M, Johnson H. Folic acid and prevention of neural tube defects in 2000 improved awareness—low peri-conceptional uptake. Ir Med J 2001; 94: 180–1, [PUBMED], [INFOTRIEVE], [CSA]